These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 217561)

  • 41. [Detection of Epstein-Barr virus specific IgE antibody].
    Ohno I; Tanno Y; Takishima T; Ida S
    Arerugi; 1990 Jan; 39(1):42-7. PubMed ID: 2161645
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Malignant lymphoma which contained EBV DNA and lacked EBNA2 antibody].
    Shimakage M; Hirai K; Ikegami N; Matsubuchi T; Kawagoe H
    Rinsho Ketsueki; 1989 Jul; 30(7):1091-2. PubMed ID: 2554014
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Distinct patterns of viral antigen expression in Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus coinfected body-cavity-based lymphoma cell lines: potential switches in latent gene expression due to coinfection.
    Callahan J; Pai S; Cotter M; Robertson ES
    Virology; 1999 Sep; 262(1):18-30. PubMed ID: 10489337
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Immunological aspects of lymphogranulomatosis].
    Blokhina NG; Agafonov VA; Bykovskaia SN; Naumova ER; Raushenbakh MO
    Ter Arkh; 1984; 56(10):125-30. PubMed ID: 6098042
    [No Abstract]   [Full Text] [Related]  

  • 45. [Immunologic changes in patients with Hodgkin's disease in clinical remission and recurrence].
    Ares BR; Sasiain MD; Brezavscek DM; Fejes M; Bachmann AE
    Medicina (B Aires); 1981; 41(3):287-92. PubMed ID: 6275237
    [No Abstract]   [Full Text] [Related]  

  • 46. [Expression of ZEBRA protein of Epstein-Barr virus in Hungarian patients with Hodgkin lymphoma: latent or lytic cycle?].
    Beck Z; Illés A; Keresztes K; Bessenyei B; Szöllosi Z; Kis A; Oláh E
    Orv Hetil; 2006 Aug; 147(33):1539-44. PubMed ID: 17037676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.
    Gronen F; Ruprecht K; Weissbrich B; Klinker E; Kroner A; Hofstetter HH; Rieckmann P
    J Neuroimmunol; 2006 Nov; 180(1-2):185-92. PubMed ID: 17023054
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus-associated peripheral T-cell and NK-cell proliferative disease/lymphoma: clinicopathologic, serologic, and molecular analysis.
    Mitarnun W; Suwiwat S; Pradutkanchana J; Saechan V; Ishida T; Takao S; Mori A
    Am J Hematol; 2002 May; 70(1):31-8. PubMed ID: 11994979
    [TBL] [Abstract][Full Text] [Related]  

  • 49. EBV-specific humoral antibodies in nasopharyngeal carcinoma patients in Cuba.
    Ruiz R; Gurtsevich V; Le Riverend E
    Neoplasma; 1979; 26(2):125-31. PubMed ID: 224330
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular immune defects to Epstein-Barr virus-determined antigens in young males.
    Masucci MG; Szigeti R; Ernberg I; Masucci G; Klein G; Chessels J; Sieff C; Lie S; Glomstein A; Businco L; Henle W; Henle G; Pearson G; Sakamoto K; Purtilo DT
    Cancer Res; 1981 Nov; 41(11 Pt 1):4284-91. PubMed ID: 6171337
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Studies of the Epstein-Barr herpesvirus relationship with Hodgkin's disease and the use of virus immunological markers in differential diagnostics of nasopharyngeal carcinoma.
    Mazurenko NP; Gurtsevich VE; Stepina VN; Plakhov IV
    Arch Geschwulstforsch; 1983; 53(3):253-9. PubMed ID: 6311138
    [No Abstract]   [Full Text] [Related]  

  • 52. Parallel tubular structures in lymphocytes. II. Correlation with cellular immunity and cytomegalovirus and Epstein-Barr virus antibodies in Hodgkin's disease.
    Halie MR; Langenhuysen MM; de Gast GC; Nieweg HO
    Acta Haematol; 1975; 54(2):82-8. PubMed ID: 169660
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Presence of elevated antibody titres to Epstein-Barr virus before Hodgkin's disease.
    Evans AS; Comstock GW
    Lancet; 1981 May; 1(8231):1183-6. PubMed ID: 6112530
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hodgkin's disease in siblings: a family study.
    Perlin E; Levine PH; McCoy J; Dean J; Herberman R
    Oncology; 1976; 33(3):116-8. PubMed ID: 189264
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Production of migration inhibitory factor (MIF) by human leukocytes following exposure to Epstein-Barr virus.
    Wilson GL; Young BG
    Cell Immunol; 1978 Jun; 38(1):147-56. PubMed ID: 208782
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune function in healthy relatives of patients with malignant disease.
    Dworsky R; Baptista J; Parker J; Chandor S; Noble G; Herrmann K; Henle W; Henderson B
    J Natl Cancer Inst; 1978 Jan; 60(1):27-30. PubMed ID: 203705
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Establishment of peripheral lymphoid cell cultures from patients with Hodgkin's disease depending on Epstein-Barr-Virus-reactivity and cellular immunity.
    Diehl V; Johansson B
    Blut; 1977 Mar; 34(3):227-36. PubMed ID: 191123
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunologic status in Hodgkin patients: correlation with Epstein-Barr virus titers].
    Diehl V; Hegge K; Kalden J; Desselberger U; Krull P
    Blut; 1976 Apr; 32(4):279-84. PubMed ID: 177135
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antibody to Epstein-Barr virus and cellular immunity in Hodgkin's disease and chronic lymphatic leukemia.
    Hesse J; Andersen E; Levine PH; Ebbesen P; Halberg P; Reisher JI
    Int J Cancer; 1973 Jan; 11(1):237-43. PubMed ID: 4364323
    [No Abstract]   [Full Text] [Related]  

  • 60. Factors in the development of AIDS-related lymphomas.
    Broder S
    Leukemia; 1992; 6 Suppl 3():6S-9S. PubMed ID: 1318478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.